Alpine Immune Sciences, Inc.盘中异动股价大涨5.33%报36.77美元_老虎社区_美港股上老虎

Alpine Immune Sciences, Inc.盘中异动股价大涨5.33%报36.77美元

自选股智能写手04-08

北京时间2024年04月08日21时51分，Alpine Immune Sciences, Inc.（ALPN.us）股票出现异动，股价急速上涨5.33%。截至发稿，该股报36.77美元/股，成交量18.2143万股，换手率0.28%，振幅6.53%。最近的财报数据显示，该股实现营业收入58.88百万美元，净利润-32.18百万美元，每股收益-0.64美元，毛利58.30百万美元，市盈率-...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2425915262?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-08 21:51","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2425915262","market":"us","top_or_hot":-1,"title":"Alpine Immune Sciences, Inc.盘中异动 股价大涨5.33%报36.77美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年04月08日21时51分，Alpine Immune Sciences, Inc.（ALPN.us）股票出现异动，股价急速上涨5.33%。截至发稿，该股报36.77美元/股，成交量18.2143万股，换手率0.28%，振幅6.53%。最近的财报数据显示，该股实现营业收入58.88百万美元，净利润-32.18百万美元，每股收益-0.64美元，毛利58.30百万美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040821514287e7e8ef&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alpine Immune Sciences, Inc.盘中异动 股价大涨5.33%报36.77美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlpine Immune Sciences, Inc.盘中异动 股价大涨5.33%报36.77美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-08 21:51 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040821514287e7e8ef&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年04月08日21时51分，Alpine Immune Sciences, Inc.（ALPN.us）股票出现异动，股价急速上涨5.33%。截至发稿，该股报36.77美元/股，成交量18.2143万股，换手率0.28%，振幅6.53%。最近的财报数据显示，该股实现营业收入58.88百万美元，净利润-32.18百万美元，每股收益-0.64美元，毛利58.30百万美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040821514287e7e8ef&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040821514287e7e8ef&s=b","article_id":"2425915262","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040821514287e7e8ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2425915262","pubTimestamp":1712584301,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年04月08日21时51分，Alpine Immune Sciences, Inc.股票出现异动，股价急速上涨5.33%。截至发稿，该股报36.77美元/股，成交量18.2143万股，换手率0.28%，振幅6.53%。Alpine Immune Sciences, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Alpine Immune Sciences, Inc.公司简介：Alpine Immune Sciences Inc 是一家临床阶段的生物制药公司，致力于发现和开发基于蛋白质的免疫疗法来治疗自身免疫性疾病和炎症性疾病。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","ALPN":"Alpine Immune Sciences Inc.","LGVN":"Longeveron Inc"},"translate_title":"Alpine Immune Sciences, Inc. rose 5.33 percent to $36.77 in intraday trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALPN":0.9,"LGVN":0.9},"content_text":"北京时间2024年04月08日21时51分，Alpine Immune Sciences, Inc.（ALPN.us）股票出现异动，股价急速上涨5.33%。截至发稿，该股报36.77美元/股，成交量18.2143万股，换手率0.28%，振幅6.53%。最近的财报数据显示，该股实现营业收入58.88百万美元，净利润-32.18百万美元，每股收益-0.64美元，毛利58.30百万美元，市盈率-56.80倍。机构评级方面，在所有8家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Alpine Immune Sciences, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Longeveron Inc.、Apollomics Inc C/Wts 01/04/2028 (To Pur Ord)、阿诺医药涨幅较大，Longeveron Inc.、Allarity Therapeutics, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为769.72%、677.84%、53.44%，振幅较大的相关个股有Longeveron Inc.、泰坦制药、Cns Pharmaceuticals, Inc.，振幅分别为99.45%、19.42%、18.10%。Alpine Immune Sciences, Inc.公司简介：Alpine Immune Sciences Inc 是一家临床阶段的生物制药公司，致力于发现和开发基于蛋白质的免疫疗法来治疗自身免疫性疾病和炎症性疾病。 它的方法包括一个专有的科学平台，可将天然免疫系统蛋白质转化为差异化的多靶点治疗药物。 它的候选管道是； ALPN-303 或 povetacicept 是 B 细胞激活因子或 BAFF 和增殖诱导配体或 APRIL 细胞因子的双重拮抗剂，后者在 B 细胞的激活、发育和存活中起关键作用，并且 ALPN-101或acazicolcept是一种双重诱导型T细胞共刺激剂（ICOS）和CD28拮抗剂，用于治疗自身免疫性疾病和炎症性疾病。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}